ROCK inhibitors could stop the spread of melanoma cells
6 May 2015 | By Victoria White
Scientists at The Institute of Cancer Research have found that ROCK inhibitors dramatically reduced the ability of melanoma cells to move through tissue...
List view / Grid view
News
Gilead acquires EpiTherapeutics for $65 million
6 May 2015 | By Victoria White
Gilead Sciences has acquired EpiTherapeutics, a scientific leader in the field of epigenetics with a library of first-in-class inhibitors, for $65 million.
MabVax Therapeutics’ HuMab 5B1 antibody successfully clears important early toxicology testing
6 May 2015 | By Victoria White
The final report on toxicology testing of HuMab 5B1 shows that it had no significant adverse findings even at the highest dosage levels tested...
ME-344 shows enhanced anti-tumour activity in combination with tyrosine-kinase inhibitor in preclinical studies
6 May 2015 | By Victoria White
MEI Pharma has announced new preclinical data showing mitochondria-specific effects of the Company's investigational drug candidate ME-344 in cancer cells...
Discovery could help reverse glucocorticoid resistance in young leukaemia patients
5 May 2015 | By
Researchers led by St. Jude Children’s Research Hospital scientists have identified a mechanism that helps leukaemia cells resist glucocorticoids...
Breast cancer vaccines may work better with silicon microparticles
5 May 2015 | By Victoria White
The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles...
Drug discovery company Selvita establishes UK subsidiary in Cambridge
5 May 2015 | By Victoria White
Selvita, a global drug discovery company with offices in the US and Poland, is opening its first office in the UK in Cambridge...
Kallistem announces a world first: human spermatogenesis in vitro
5 May 2015 | By Victoria White
Kallistem has produced a fully formed human spermatozoa in the laboratory setting, using patient testicular biopsies containing only immature germ cells...
Shire and Foundation Fighting Blindness announce new adRP research agreement
5 May 2015 | By Victoria White
Shire and the Foundation Fighting Blindness have entered in to an agreement focused on furthering research for a novel treatment for adRP...
The Michael J. Fox Foundation and Prothena partner to accelerate discovery of novel biomarkers for Parkinson’s disease
5 May 2015 | By Victoria White
MJFF and Prothena have teamed up to accelerate the discovery of novel biomarkers and development of assays to measure Parkinson's disease progression...
ReNeuron gets approval to start a Phase I/II clinical trial in the US in retinitis pigmentosa
5 May 2015 | By Victoria White
ReNeuron has received approval from the FDA to commence a Phase I/II clinical trial in the US with its hRPC therapy candidate for retinitis pigmentosa...
Scientists identify key receptors behind development of acute myeloid leukaemia
30 April 2015 | By Victoria White
Researchers have found that ITIM - receptors are important to the development of acute myeloid leukaemia (AML), providing a target for potential therapies...
New method of investigating human lung tissue enables improved drug target validation for COPD treatment
30 April 2015 | By Victoria White
Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating COPD on ex vivo 3D-LTCs...
NIH to fund $10.5 million multi-site, interdisciplinary research effort to investigate the role of non-inherited genetic mutations in schizophrenia
30 April 2015 | By Victoria White
NIH funded project to identify the causes of schizophrenia and other neurodevelopmental disorders to guide development of more effective treatments...
Biotech companies present novel approaches to fight infections at ECCMID’s pipeline corner
30 April 2015 | By Victoria White
Biotech companies presented new mechanisms and approaches in the global fight against infections in a pipeline session at ECCMID...
